drugset / Trial / NCT01894568
A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare insulin peglispro (LY2605541) to insulin glargine in Asian insulin naïve participants who have been treated with oral anti hyperglycemia medications. Participants will receive 26 weeks of treatment.
Timeline
- Start
- 2013-07
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin Peglispro | Protein / enzyme biologic | — | Subcutaneous |
| Comparator | insulin glargine | Protein / enzyme biologic | — | Subcutaneous |
| Background | Pioglitazone | Small molecule | — | Oral |